| Date | Form | Description | Docs | XBRL | Pages |
| 11/13/13 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 11/13/13 | 8-K | Current report filing |
|
8 | |
| 10/16/13 | 8-K | Current report filing |
|
4 | |
| 10/02/13 | 424B3 | Prospectus filed pursuant to Rule 424(b)(3) |
|
60 | |
| 09/20/13 | 10-Q/A | Quarterly report pursuant to sections 13 or 15(d) |
|
|
3 |
| 09/16/13 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
66 | |
| 09/09/13 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 08/27/13 | ARS | Annual report to security holders |
|
108 | |
| 08/27/13 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
|
3 | |
| 08/27/13 | DEF 14A | Definitive proxy statements |
|
36 |
Latest News & Events
Anixa Biosciences to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference on May 20th
Read More...Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for CAR-T Technology, Further Strengthening its Robust Intellectual Property Portfolio
Read More...Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for Patent Covering Breast Cancer Vaccine Technology
Read More...